{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:16:20Z","timestamp":1767676580208},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/bf03343732","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T04:56:45Z","timestamp":1394513805000},"page":"328-338","source":"Crossref","is-referenced-by-count":26,"title":["RET proto-oncogene mutations in thyroid carcinomas: Clinical relevance"],"prefix":"10.1007","volume":"23","author":[{"given":"F.","family":"Pacini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Romei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinchera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343732_CR1","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1073\/pnas.94.12.6238","volume":"94","author":"M Sanicola","year":"1997","unstructured":"Sanicola M., Hession C., Worley D., Carmillo P., Ehrenfels C., Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A., Pepinsky R.B., Cate R.L. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cellsurface accessory proteins. Proc. Natl. Acad. Sci. USA 1997, 94: 6238\u20136243.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03343732_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","volume":"60","author":"M Grieco","year":"1990","unstructured":"Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R., Bongarzone I., Pierotti M.A., Della Porta G., Fusco A., Vecchio G. PTC is a novel rearranged form of the Ret protooncogene and is frequently detected in vivo in human thyroid papillary carcinoma. Cell 1990, 60: 557\u2013663.","journal-title":"Cell"},{"key":"BF03343732_CR3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/BF03343650","volume":"22","author":"M Santoro","year":"1999","unstructured":"Santoro M., Carlomagno F., Melillo R.M., Billaud M., Vecchio G., Fusco A. Molecular mechanisms of RET activation in human neoplasia. J. Endocrinol. Invest. 1999, 22: 811\u2013819.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343732_CR4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI115743","volume":"89","author":"M Santoro","year":"1992","unstructured":"Santoro M., Carlomagno F., Hay I.D., Herrmann M.A., Grieco M., Melillo R., Pierotti M.A., Bongarzone I., Della Porta G., Berger N., Peix J.L., Paulin C., Fabien N., Vecchio G., Jenkins R.B., Fusco A. Ret oncogene activation in human thyroid neoplasm is restricted to the papillary cancer subtype. J. Clin. Invest. 1992, 89: 1517\u20131522.","journal-title":"J. Clin. Invest."},{"key":"BF03343732_CR5","first-page":"1667","volume":"6","author":"Y Ishizaka","year":"1991","unstructured":"Ishizaka Y., Kobayashi S., Ushijima T., Hirohaschi S., Sugimura T., Nagao M. Detection of RET\/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 1991, 6: 1667\u20131672.","journal-title":"Oncogene"},{"key":"BF03343732_CR6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.onc.1200206","volume":"15","author":"A Bounacer","year":"1997","unstructured":"Bounacer A., Wicker R., Caillou B., Cailleux A.F., Sarasin A., Schlumberger M., Suarez H.G. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 1997, 15: 1263\u20131273.","journal-title":"Oncogene"},{"key":"BF03343732_CR7","first-page":"1207","volume":"11","author":"G Viglietto","year":"1995","unstructured":"Viglietto G., Chiappetta G., Martinez-Tello F.J., Fukunaga F.H., Tallini G., Rigopoulou D., Visconti R., Mastro A., Santoro M., Fusco A. RET\/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 1995, 11: 1207\u20131210.","journal-title":"Oncogene"},{"key":"BF03343732_CR8","first-page":"4116","volume":"83","author":"SL Sugg","year":"1998","unstructured":"Sugg S.L, Ezzat S., Rosen I.B., Freeman J.L., Asa S.L. Distinct multiple RET\/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J. Clin. Endocrinol. Metab. 1998, 83: 4116\u20134122.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR9","first-page":"1457","volume":"4","author":"I Bongarzone","year":"1994","unstructured":"Bongarzone I., Pierotti M.A., Monzini N., Mondellini P., Manenti G., Donghi R., Pilotti S., Grieco M., Santoro M., Fusco A., Vecchio G., Della Porta G. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1994, 4: 1457\u20131462.","journal-title":"Oncogene"},{"key":"BF03343732_CR10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1349-7006.1992.tb01963.x","volume":"83","author":"W Wajjwalku","year":"1992","unstructured":"Wajjwalku W., Nakamura S., Hasegawa Y., Miyazaki K., Satoh Y., Funahashi H., Matsuyama M., Takahashi M. Low frequency of rearrangements of the RET and TRK proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn. J. Cancer Res. 1992, 83: 671\u2013675.","journal-title":"Jpn. J. Cancer Res."},{"key":"BF03343732_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1097-0142(19940101)73:1<176::AID-CNCR2820730130>3.0.CO;2-T","volume":"73","author":"M Zou","year":"1994","unstructured":"Zou M., Shi Y., Farid N.R. Low rate of ret proto-oncogene activation (PTC\/ RET) in papillary thyroid carcinomas from Saudi Arabia. Cancer 1994, 73: 176\u2013180.","journal-title":"Cancer"},{"key":"BF03343732_CR12","first-page":"1331","volume":"7","author":"SM Jhiang","year":"1992","unstructured":"Jhiang S.M., Caruso D.R., Gilmore E., Ishizaka Y., Tahira T., Nagao M., Chiu I.M., Mazzaferri E.L. Detection of the PTC\/retPTC oncogene in human thyroid cancers. Oncogene 1992, 7: 1331\u20131337.","journal-title":"Oncogene"},{"key":"BF03343732_CR13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2265.1998.00515.x","volume":"49","author":"KY Park","year":"1998","unstructured":"Park K.Y., Koh J.M., Kim Y.I., Park H.J., Gong G., Hong S.J., Ahn I.M. Prevalences of Gs alpha, ras, p53 mutations and ret\/PTC rearrangement in differentiated thyroid tumours in a Korean population. Clin. Endocrinol. (Oxf.) 1998, 49: 317\u2013323.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343732_CR14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1998.149","volume":"77","author":"B Mayr","year":"1998","unstructured":"Mayr B., Potter E., Goretzki P., Ruschoff J., Dietmaier W., Hoang-Vu C., Dralle H., Brabant G. Expression of Ret\/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Br. J. Cancer 1998, 77: 903\u2013906.","journal-title":"Br. J. Cancer"},{"key":"BF03343732_CR15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<32::AID-IJC7>3.0.CO;2-L","volume":"80","author":"J Smida","year":"1999","unstructured":"Smida J., Salassidis K., Hieber L., Zitzelsberger H., Kellerer A.M., Demidchik E.P., Negele T., Spelsberg F., Lengfelder E., Werner M., Bauchinger M. Distinct frequency of Ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int. J. Cancer 1999, 80: 32\u201338.","journal-title":"Int. J. Cancer"},{"key":"BF03343732_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1996.405","volume":"74","author":"GH Williams","year":"1996","unstructured":"Williams G.H., Rooney S., Thomas G.A., Cummings G., Williams E.D. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archivial-nested material. Br. J. Cancer 1996, 74: 585\u2013589.","journal-title":"Br. J. Cancer"},{"key":"BF03343732_CR17","first-page":"1629","volume":"83","author":"CH Lee","year":"1998","unstructured":"Lee C.H., Hsu L.S., Chi C.W., Chen G.D., Yang A.H., Chen J.Y. High frequency of rearrangement of the ret protooncogene (RET\/PTC) in Chinese papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 1998, 83: 1629\u20131632.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/thy.1999.9.1237","volume":"9","author":"JH Chung","year":"1999","unstructured":"Chung J.H., Hahm J.R., Min Y.K., Lee M.S., Lee M.K., Kim K.W., Nam S.J., Yang Y.H., Ree H.J. Detection of RET\/PTC oncogene rearrangements in Korean papillary thyroid carcinomas. Thyroid 1999, 9: 1237\u20131243.","journal-title":"Thyroid"},{"key":"BF03343732_CR19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/thy.1998.8.485","volume":"8","author":"T Motomura","year":"1998","unstructured":"Motomura T., Nikiforov Y.E., Namba H., Ashizawa K., Nagataki S., Yamashita S., Fagin J.A. Ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 1998, 8: 485\u2013489.","journal-title":"Thyroid"},{"key":"BF03343732_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.0.CO;2-S","volume":"185","author":"P Soares","year":"1998","unstructured":"Soares P., Fonseca E., Wynford-Thomas D., Sobrinho-Simoes M. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J. Pathol. 1998, 185: 71\u201378.","journal-title":"J. Pathol."},{"key":"BF03343732_CR21","first-page":"2006","volume":"81","author":"I Bongarzone","year":"1996","unstructured":"Bongarzone I., Fugazzola L., Vigneri P., Mariani L., Mondellini P., Pacini F., Basolo F., Pinchera A., Pilotti S., Pierotti M.A. Age-related activation of the tyrosine kinase receptor proto-oncogene ret and ntrk 1 in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81: 2006\u20132009.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR22","first-page":"1690","volume":"57","author":"YE Nikiforov","year":"1997","unstructured":"Nikiforov Y.E., Rowland J.M., Bove K.E., Monforte-Munoz H., Fagin J.A. Distinct pattern of Ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 1997, 57: 1690\u20131694.","journal-title":"Cancer Res."},{"key":"BF03343732_CR23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/thy.1998.8.1003","volume":"8","author":"AV Pisarchik","year":"1998","unstructured":"Pisarchik A.V., Ermak G., Demidchik E.P., Mikhalevich L.S., Kartel N.A., Figge J. Low prevalence of the ret\/PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten years post-Chernobyl. Thyroid 1998, 8: 1003\u20131008.","journal-title":"Thyroid"},{"key":"BF03343732_CR24","first-page":"5617","volume":"55","author":"L Fugazzola","year":"1995","unstructured":"Fugazzola L., Pilotti S., Pinchera A., Vorontsova T.V., Mondellini P., Bongarzone I., Greco A., Astakhova L., Butti M.G., Demidchick E.P., Pacini F., Pierotti M.A. Oncogenic rearrangements of the Ret proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 1995, 55: 5617\u20135620.","journal-title":"Cancer Res."},{"key":"BF03343732_CR25","first-page":"2459","volume":"11","author":"S Klugbauer","year":"1995","unstructured":"Klugbauer S., Lengfelder E., Demidchik E.P., Rabes H.M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995, 11: 2459\u20132467.","journal-title":"Oncogene"},{"key":"BF03343732_CR26","first-page":"4232","volume":"84","author":"GA Thomas","year":"1999","unstructured":"Thomas G.A., Bunnell H., Cook H.A., Williams E.D., Nerovnya A., Cherstvoy D., Tronko N.D., Bogdanova T.I., Chiappetta G., Viglietto G., Pentimalli F., Salvatore G., Fusco A., Santoro M., Vecchio G. High prevalence of RET\/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET\/PTC3 and the solid-follicular variant. J. Clin. Endocrinol. Metab. 1999, 84: 4232\u20134238.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR27","first-page":"5","volume-title":"\u201cNagasaki Symposium: Radiation research III\u201d","author":"V Saenko","year":"1999","unstructured":"Saenko V., Romei C., Elisei R., Abrosimov A., Roumantsiev P., Lushnikov E., Pacini F. Rate of the RET\/PTC rearrangements in post-Chernobyl childhood and adolescent thyroid carcinomas in Russia. In: \u201cNagasaki Symposium: Radiation research III\u201d, 6 August 1999, Nagasaki, Japan (Abs, pag. 5)."},{"key":"BF03343732_CR28","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1038\/sj.onc.1203019","volume":"18","author":"YE Nikiforov","year":"1999","unstructured":"Nikiforov Y.E., Koshoffer A., Nikiforova M., Stringer J., Fagin J.A. Chromosomal break point positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE 1 and RET genes in radiation induced thyroid carcinomas. Oncogene 1999, 18: 6330\u20136334.","journal-title":"Oncogene"},{"key":"BF03343732_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger M.J. Medical progress: Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338: 297\u2013306.","journal-title":"N. Engl. J. Med."},{"key":"BF03343732_CR30","first-page":"331","volume":"123","author":"SM Jhiang","year":"1994","unstructured":"Jhiang S.M., Mazzaferri E.L. The ret\/PTC oncogene in papillary thyroid carcinoma. J. Lab. Clin. Med 1994, 123: 331\u2013337.","journal-title":"J. Lab. Clin. Med"},{"key":"BF03343732_CR31","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jcem.81.9.8784097","volume":"81","author":"SL Sugg","year":"1996","unstructured":"Sugg S.L., Zheng L., Rosen I.B., Freeman J.L., Ezzat S., Asa S.L. ret\/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential? J. Clin. Endocrinol. Metab. 1996, 81: 3360\u20133365.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR32","first-page":"287","volume":"4","author":"G Tallini","year":"1998","unstructured":"Tallini G., Santoro M., Helie M., Carlomagno F., Salvatore G., Chiappetta G., Carcangiu M.L., Fusco A. RET\/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin. Cancer Res. 1998, 4: 287\u2013294.","journal-title":"Clin. Cancer Res."},{"key":"BF03343732_CR33","first-page":"51","volume":"22","author":"L Pollina","year":"1999","unstructured":"Pollina L., Agate L., Basolo F., Molinaro E., Baldanzi A., Pacini F., Chiappetta G., Salvatore G., Santoro M., Fusco A. RET\/PTC activation in papillary thyroid carcinomas analyzed by immunohistochemistry. J. Endocrinol. Invest. 1999, 22 (Suppl.): 51.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343732_CR34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan L.M., Kwok J.B., Healey C.S., Elsdon M.J., Eng C., Gardner E., Love D.R., Mole S.E., Moore J.K., Papi L. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363: 458\u2013460.","journal-title":"Nature"},{"key":"BF03343732_CR35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H., Dou S., Chi D., Carlson K.M., Toshima K., Lairmore T.C., Howe J.R., Moley J.F., Goodfellow P., Wells S.A. Jr. Mutations in the RET proto-oncogene are associated with MEN IIA and FMTC. Hum. Mol. Genet. 1993, 2: 851\u2013856.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","volume":"3","author":"C Eng","year":"1994","unstructured":"Eng C., Smith D.P., Mulligan L.M., Nagai M.A., Healey C.S., Ponder M.A., Gardner E., Scheumann G.F., Jackson C.E., Tunnacliffe A. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 1994, 3: 237\u2013241.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR37","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","volume":"91","author":"KM Carlson","year":"1994","unstructured":"Carlson K.M., Dou S., Chi D., Scavarda N., Toshima K., Jackson C.E., Wells S.A. Jr., Goodfellow P.J., Donis-Keller H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA 1994, 91: 1579\u20131583.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03343732_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","volume":"367","author":"RMW Hofstra","year":"1994","unstructured":"Hofstra R.M.W., Landsvater R.M., Ceccherini I., Stulp R.P., Stelwagen T., Luo Y., Pasini B., Hoppener J.W., van Amstel H.K., Romeo G. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994, 367: 375\u2013376.","journal-title":"Nature"},{"key":"BF03343732_CR39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R., von Amstel H.K.P., Lips C.J.M., Nishisho I., Takai S., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordonskjold M., Komminoth P., Hendy G., Gharib H., Thibodeau S.N., Lacroix A., Frilling A., Ponder B.A.J., Mulligan L.M. The realtionship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis. JAMA 1996, 276: 1575\u20131579.","journal-title":"JAMA"},{"key":"BF03343732_CR40","first-page":"770","volume":"83","author":"I Berndt","year":"1997","unstructured":"Berndt I., Reuter M., Saller B., Frank-Raue K., Groyh P., Grubendorf M., Raue F., Ritter M.M., Hoppner W. A new hotspot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and MEN 2A. J. Clin. Endocrinol. Metab. 1997, 83: 770\u2013774.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4065\/72.5.430","volume":"72","author":"HM Heshmati","year":"1997","unstructured":"Heshmati H.M., Gharib H., Khosla S., Abu-Lebdeh H.S., Lindor N.M., Thibodeau S.N. Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance. Mayo Clin. Proc. 1997, 72: 430\u2013436.","journal-title":"Mayo Clin. Proc."},{"key":"BF03343732_CR42","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/3.11.1939","volume":"3","author":"I Schuffenecker","year":"1994","unstructured":"Schuffenecker I., Billaud M., Calender A., Chambe B., Ginet N., Calmettes C., Modigliani E., Lenoir G.M. RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum. Mol. Genet. 1994, 3: 1939\u20131943.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR43","first-page":"68","volume":"36","author":"B Sanchez","year":"1999","unstructured":"Sanchez B., Robledo M., Biarnes J., Saez M.E., Volpini V., Benitez J., Navarro E., Ruiz A., Antinolo G., Borrego S. High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. J. Med. Genet. 1999, 36: 68\u201370.","journal-title":"J. Med. Genet."},{"key":"BF03343732_CR44","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jcem.82.11.4508","volume":"82","author":"O Gimm","year":"1997","unstructured":"Gimm O., Marsh D.J., Andrew S.D., Frilling A., Dahia P.L., Mulligan L.M., Zajac J.D., Robinson B.G., Eng C. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J. Clin. Endocrinol. Metab. 1997, 82: 3902\u20133904.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR45","first-page":"4176","volume":"82","author":"RMW Hofstra","year":"1997","unstructured":"Hofstra R.M.W., Fattoruso O., Quadro L., Wu Y., Libroia A., Verga U., Colantuoni V., Buys C.H.C.M. A novel point mutation in the intracellular domain of the RET proto-oncogene in a family with medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1997, 82: 4176\u20134178.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.1999.tb00658.x","volume":"90","author":"A Miyauchi","year":"1999","unstructured":"Miyauchi A., Futami H., Hai N., Yokozawa T., Kuma K., Aoki N., Kosugi S., Sugano K., Yamaguchi K. Two germline missense mutations at codon 804 and 806 of the RET proto-oncogene in the same allele in a patient with MEN 2B without codon 918 mutation. Jpn. J. Cancer Res. 1999, 90: 1\u20135.","journal-title":"Jpn. J. Cancer Res."},{"key":"BF03343732_CR47","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","volume":"15","author":"DP Smith","year":"1997","unstructured":"Smith D.P., Houghton C., Ponder B.A.J. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 1997, 15: 1213\u20131217.","journal-title":"Oncogene"},{"key":"BF03343732_CR48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0039-6060(05)80110-2","volume":"118","author":"F Pacini","year":"1995","unstructured":"Pacini F., Romei C., Miccoli P., Elisei R., Molinaro E., Mancusi F., Iacconi P., Basolo F., Martino E., Pinchera A. Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for RET gene mutations. Surgery 1995, 118: 1031\u20131035.","journal-title":"Surgery"},{"key":"BF03343732_CR49","first-page":"54","volume":"22","author":"V Bottici","year":"1999","unstructured":"Bottici V., Elisei R., Molinaro E., Vivaldi A. Genetic screening of RET proto-oncogene mutations in medullary thyroid carcinoma (MTC): a 6-year experience. J. Endocrinol. Invest. 1999, 22 (Suppl.): 54.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343732_CR50","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0039-6060(05)80120-5","volume":"118","author":"A Frilling","year":"1995","unstructured":"Frilling A., Dralle H., Eng C., Raue F., Broelsch C.E. Presymptomatic DNA screening in families with multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Surgery 1995, 118: 1099\u20131103.","journal-title":"Surgery"},{"key":"BF03343732_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2008-1047588","volume":"122","author":"K Frank-Raue","year":"1997","unstructured":"Frank-Raue K., Hoppner W., Buhr H., Herfarth C., Ziegler R., Raue F. Mutations of the ret proto-oncogene in thyroid medullary carcinoma. Dtsch. Med. Wochenschr. 1997, 122: 143\u2013149.","journal-title":"Dtsch. Med. Wochenschr."},{"key":"BF03343732_CR52","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","volume":"331","author":"CJM Lips","year":"1994","unstructured":"Lips C.J.M., Landsvater R.M., Hoppner W.M., Geerdink R.A., Blijham G., van Veen J.S., van Gils A., de Wit M.J., Zewald R.A., Berends M.J.H., Beemer F.A., Brouwers-Smalbraak J., Jansen R.P.M., van Amstel H.K.P., van Vroonhoven T.J.M.V., Vroom T.M. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N. Engl. J. Med. 1994, 331: 828\u2013833.","journal-title":"N. Engl. J. Med."},{"key":"BF03343732_CR53","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/019459988910100411","volume":"101","author":"LJ Shemen","year":"1989","unstructured":"Shemen L.J., Strong E.W. Complications after total thyroidectomy. Otolaryngol. Head Neck Surg. 1989, 101: 472\u2013475.","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"BF03343732_CR54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1288\/00005537-198912000-00005","volume":"99","author":"F Tovi","year":"1989","unstructured":"Tovi F., Noyek A.M., Chapnik J.S., Freeman J.L. Safety of total thyroidectomy: review of 100 consecutive cases. Laryngoscope 1989, 99: 1233\u20131237.","journal-title":"Laryngoscope"},{"key":"BF03343732_CR55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1445-2197.1992.tb00003.x","volume":"62","author":"M Khadra","year":"1992","unstructured":"Khadra M., Delbridge L., Reeve T.S., Poole A.G., Crummer P. Total thyroidectomy: its role in the management of thyroid disease. Aust. N.Z. J. Surg. 1992, 62: 91\u201395.","journal-title":"Aust. N.Z. J. Surg."},{"key":"BF03343732_CR56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archotol.1991.01870170062014","volume":"117","author":"J Herranz-Gonzales","year":"1991","unstructured":"Herranz-Gonzales J., Gavilan J., Matinez-Vidal J., Gavilan C. Complications following thyroid surgery. Arch. Otolaryngol. Head Neck Surg. 1991, 117: 516.","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"BF03343732_CR57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJM197308302890901","volume":"289","author":"HJ Wolfe","year":"1973","unstructured":"Wolfe H.J., Melvin K.E., Cervi-Skinner S.J., Saadi A.A., Juliar J.F., Jackson C.E., Tashjian A.H. Jr. C-cell hyperplasia preceding medullary thyroid carcinoma. N. Engl. J. Med. 1973, 289: 437\u2013441.","journal-title":"N. Engl. J. Med."},{"key":"BF03343732_CR58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(94)91739-6","volume":"344","author":"F Pacini","year":"1994","unstructured":"Pacini F., Martino E., Romei C., Ceccherini I., Basolo F., Iacconi P., Pinchera A. Treatment of preclinical medullary thyroid carcinoma in MEN 2A gene carrier. Lancet 1994, 344: 1084\u20131085.","journal-title":"Lancet"},{"key":"BF03343732_CR59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s002689900463","volume":"22","author":"H Dralle","year":"1998","unstructured":"Dralle H., Gimm O., Simon D., Frank-Raue K., Gortz G., Niederle B., Wahl R.A., Koch B., Walgenbach S., Hampl R., Ritter M.M., Spelsberg F., Heiss A., Hinze R., Hoppner W. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J. Surg. 1998, 22: 750\u2013751.","journal-title":"World J. Surg."},{"key":"BF03343732_CR60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.1995.tb01207.x","volume":"238","author":"RF Gagel","year":"1995","unstructured":"Gagel R.F., Cote G.J., Martins Bugalho M.J., Boyd A.E. III, Cummings T., Goepfert H., Evans D.B., Cangir A., Khorana S., Schultz P.N. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J. Intern. Med. 1995, 238: 333\u2013341.","journal-title":"J. Intern. Med."},{"key":"BF03343732_CR61","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1997.01430330088015","volume":"132","author":"DL Learoyd","year":"1997","unstructured":"Learoyd D.L., Marsh D.J., Richardson A.L., Twigg S.M., Delbridge L., Robinson B.G. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Arch. Surg. 1997, 132: 1022\u20131025.","journal-title":"Arch. Surg."},{"key":"BF03343732_CR62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","volume":"2203","author":"S Wells Jr","year":"1994","unstructured":"Wells S. Jr, Chi D., Toshima K., Dehner L., Coffin C.M., Dowton S.B., Ivanovich J.L., DeBenedetti M.K., Dilley W.G., Moley J.F. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann. Surg. 1994, 2203: 237\u2013247.","journal-title":"Ann. Surg."},{"key":"BF03343732_CR63","first-page":"1619","volume":"81","author":"C Romei","year":"1996","unstructured":"Romei C., Elisei R., Pinchera A., Ceccherini I., Molinaro E., Mancusi F., Martino E., Romeo G., Pacini F. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J. Clin. Endocrinol. Metab. 1996, 81: 1619\u20131622.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR64","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","volume":"3","author":"J Zedenius","year":"1994","unstructured":"Zedenius J., Wallin G., Hamberger B., Nordenskjold M., Weber G., Larsson C. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum. Mol. Genet. 1994, 3: 1259\u20131262.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/gcc.2870120308","volume":"12","author":"C Eng","year":"1995","unstructured":"Eng C., Mulligan L.M., Smith D.P., Healey C.S., Frilling A., Raue F., Neumann H.P.H., Pfranger R., Behmel A., Lorenzo M.J., Stonehouse T.J., Ponder M.A., Ponder B.A.J. Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chromosom. Cancer 1995, 12: 209\u2013212.","journal-title":"Genes Chromosom. Cancer"},{"key":"BF03343732_CR66","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/3.10.1895","volume":"3","author":"JE Blaugrund","year":"1994","unstructured":"Blaugrund J.E., Johns M. Jr, Eby Y.J., Ball D.W., Baylin S.B., Hruban R.H., Sidransky D. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum. Mol. Genet. 1994, 3: 1895\u20131897.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.1996.681503.x","volume":"44","author":"DJ Marsh","year":"1996","unstructured":"Marsh D.J., Learoyd D.L., Andrew S.D., Krisnan L., Pojer R., Richardson A., Delbridge L., Eng C., Robinson B.G. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin. Endocrinol. 1996, 44: 249\u2013254.","journal-title":"Clin. Endocrinol."},{"key":"BF03343732_CR68","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1038\/sj.onc.1201079","volume":"14","author":"I Ceccherini","year":"1997","unstructured":"Ceccherini I., Pasini B., Pacini F., Gullo M., Bongarzone I., Romei C., Santamaria G., Matera I., Mondellini P., Scopsi L., Pinchera A., Pierotti M.A., Romeo G. Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene. Oncogene 1997, 14: 2609\u20132612.","journal-title":"Oncogene"},{"key":"BF03343732_CR69","first-page":"2619","volume":"16","author":"M Alemi","year":"1996","unstructured":"Alemi M., Lucas S.D., Sallstrom J.F., Akerstrom G., Wilander E.A. Novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma. Anticancer Res. 1996, 16: 2619\u20132622.","journal-title":"Anticancer Res."},{"key":"BF03343732_CR70","first-page":"2063","volume":"80","author":"C Beldjord","year":"1995","unstructured":"Beldjord C., Desclaux-Arramond F., Raffin-Sanson M., Corvol J.C., De Keyzer Y., Luton J.P., Plouin P.F., Bertagna X. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. Clin. Endocrinol. Metab. 1995, 80: 2063\u20132068.","journal-title":"Clin. Endocrinol. Metab."},{"key":"BF03343732_CR71","first-page":"627","volume":"80","author":"NM Lindor","year":"1995","unstructured":"Lindor N.M., Honchel R., Khosla S., Thibodeau S.N. Mutations in the RET protooncogene in sporadic pheochromocytomas. J. Clin. Endocrinol. Metab. 1995, 80: 627\u2013629.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR72","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jmg.32.12.934","volume":"32","author":"C Eng","year":"1995","unstructured":"Eng C., Crossey P.A., Mulligan L.M., Healey C.S., Houghton C., Prowse A., Chew S.L., Dahia P.L., O\u2019Riordan J.L., Toledo S.P. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Med. Genet. 1995, 32: 934\u2013937.","journal-title":"Med. Genet."},{"key":"BF03343732_CR73","first-page":"1600","volume":"147","author":"BC Padberg","year":"1995","unstructured":"Padberg B.C., Schroder S., Jochum W., Kastendieck H., Roth J., Heitz P.U., Komminoth P. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am. J. Pathol. 1995, 147: 1600\u20131607.","journal-title":"Am. J. Pathol."},{"key":"BF03343732_CR74","first-page":"2711","volume":"81","author":"Z Pausova","year":"1996","unstructured":"Pausova Z., Soliman E., Amizuka N., Janicic N., Konrad E.M., Arnold A., Goltzman D., Hendy G.N. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. J. Clin. Endocrinol. Metab. 1996, 81: 2711\u20132718.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR75","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","volume":"3","author":"J Zedenius","year":"1994","unstructured":"Zedenius J., Wallin G., Hamberger B., Nordenskjold M., Weber G., Larsson C. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs. Hum. Mol. Genet. 1994, 3: 1259\u20131262.","journal-title":"Hum. Mol. Genet."},{"key":"BF03343732_CR76","first-page":"2167","volume":"56","author":"C Eng","year":"1996","unstructured":"Eng C., Mulligan L.M., Healey C.S., Houghton C., Frilling A., Raue F., Thomas G.A., Ponder B.A. Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res. 1996, 56: 2167\u20132170.","journal-title":"Cancer Res."},{"key":"BF03343732_CR77","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s004390050339","volume":"99","author":"AM Ferraris","year":"1997","unstructured":"Ferraris A.M., Mangerini R., Gaetani G.F., Romei C., Pinchera A., Pacini F. Polyclonal origin of medullary carcinoma of the thyroid in multiple endocrine neoplasia type 2. Hum. Genet. 1997, 99: 202\u2013205.","journal-title":"Hum. Genet."},{"key":"BF03343732_CR78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0039-6060(05)80332-0","volume":"118","author":"RA Decker","year":"1995","unstructured":"Decker R.A., Peacock M.L., Borst M.J., Sweet J.D., Thompson N.W. Progress in genetic screening of multiple endocrine neoplasia type 2A: Is calcitonin testing obsolete? Surgery 1995, 118: 257\u2013263.","journal-title":"Surgery"},{"key":"BF03343732_CR79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","volume":"43","author":"C Eng","year":"1995","unstructured":"Eng C., Mulligan L.M., Smith D.P., Healey C.S., Frilling A., Raue F., Neumann H.P., Ponder M.A., Ponder B.A. Low frequency of germline mutations in sporadic medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 1995, 43: 123\u2013127.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343732_CR80","first-page":"37","volume":"81","author":"N Wohlik","year":"1996","unstructured":"Wohlik N., Cote G.J., Bugalho M.M.J. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 1996, 81: 37\u201340.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343732_CR81","first-page":"233","volume":"60","author":"I Schuffenecker","year":"1997","unstructured":"Schuffenecker I., Ginet N., Goldgar D., Eng C., Chambe B., Boneu A., Houdent C., Pallo D., Schlumberger M., Thivolet C., Lenoir G.M. Prevalence and parental origin of de novo RET mutations in MEN 2A and FMTC. Am. J. Hum. Genet. 1997, 60: 233\u2013237.","journal-title":"Am. J. Hum. Genet."},{"key":"BF03343732_CR82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19950801)76:3<479::AID-CNCR2820760319>3.0.CO;2-M","volume":"76","author":"P Komminoth","year":"1995","unstructured":"Komminoth P., Kunz E.K., Matias-Guiu X., Hiort O., Christiansen G., Colomer A., Roth J., Heitz P.U. Analysis of the RET proto-oncogene point mutations distinguishes heritable from non heritable medullary thyroid carcinomas. Cancer 1995, 76: 479\u2013489.","journal-title":"Cancer"},{"key":"BF03343732_CR83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF03350771","volume":"21","author":"E Chiefari","year":"1998","unstructured":"Chiefari E., Russo D., Giuffrida D., Zampa G.A., Meringolo D., Arturi F., Chiodini I., Bianchi D., Attard M., Trischitta V., Bruno R., Giannasio P., Pontecorvi A., Filetti S. Analysis of ret proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. J. Endocrinol. Invest. 1998, 21: 358\u2013364.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343732_CR84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s100380050048","volume":"43","author":"S Shirahama","year":"1998","unstructured":"Shirahama S., Ogura K., Takami H., Ito K., Tohsen T., Miyauchi A., Nakamura Y. Mutational analysis of the ret proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J. Hum. Genet. 1998, 43: 101\u2013106.","journal-title":"J. Hum. Genet."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343732\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:31:13Z","timestamp":1565242273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["BF03343732"],"URL":"https:\/\/doi.org\/10.1007\/bf03343732","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}